secwatch.observer — SEC 8-K summary
======================================

Issuer:     Byrn, Inc. (BRRN)
CIK:        0001397795
Form:       8-K
Filed at:   2026-05-11T20:01:31+00:00
Accession:  0001213900-26-054461
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.01, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Bryn Inc. undergoes change in control; MEDO Healthcare acquires 84.7% voting power, new CEO appointed
--------------------------------------------------------------------------------

- On April 24, 2026, MEDO Healthcare LLC purchased 10M shares of Series A-1 Preferred Stock for $175,000 cash, gaining 84.7% voting power.
- David Lazar resigned as sole officer/director; John Leo appointed as sole director and CEO, Arthur Magee as CFO and Secretary.
- John Leo holds 27.4% membership interest in MEDO Healthcare and also owns Primary Capital LLC.
- New management team has extensive investment banking and capital markets experience.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1397795/000121390026054461/0001213900-26-054461-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1397795/000121390026054461/ea0289997-8k_bryninc.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-054461

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer